ipamorelin clinical trial growth hormone release safety vs Tesamorelin: Differences Explained – PlexusDx An Exploration into the Potential
Description
discussion 638-40
PMID: 30612991
[DOI] [PubMed] [Google Scholar] 115.Anderson P.M., Bielack S.S., Gorlick R.G., Skubitz K., Daw N.C., Herzog C.E., Monge O.R., Lassaletta A., Boldrini E., Ppai Z., et al
LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway
doi: 10.1111/j.1468-1293.2010.00906.x
Mortazavi, M
